表紙:タンパク質治療薬の世界市場、規模調査&予測、製品別、用途別、地域別分析、2023~2030年
市場調査レポート
商品コード
1381647

タンパク質治療薬の世界市場、規模調査&予測、製品別、用途別、地域別分析、2023~2030年

Global Protein Therapeutics Market Size Study & Forecast, by Product, By Application, and Regional Analysis, 2023-2030

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
タンパク質治療薬の世界市場、規模調査&予測、製品別、用途別、地域別分析、2023~2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のタンパク質治療薬市場は、2022年に約3,253億5,000万米ドルと評価され、予測期間2023~2030年には7.1%以上の健全な成長率で成長すると予測されています。

タンパク質治療薬は、タンパク質またはペプチドをベースとする治療薬の一群を指します。タンパク質は、免疫機能、代謝、細胞シグナル伝達など、さまざまな生物学的機能に不可欠な実質的分子です。これらの治療化合物は、受容体、酵素、シグナル伝達分子など、特定の身体標的と相互作用することによって、病気、障害、病状を治療することを目的としています。良好な規制環境、高齢者人口の増加、生物製剤分野の開拓に加え、医療支出の増加が、全世界の市場需要に拍車をかけている主な要因です。

さらに、がん、糖尿病、心血管障害、自己免疫疾患などの慢性疾患の有病率の上昇が、推定期間中のタンパク質治療薬の需要を促進しています。National Cancer Instituteによると、2018年のがん患者数は1,810万人と推定され、2040年には2,950万人に達すると予測されています。さらに、国際糖尿病連合(IDF)の報告によると、2021年には約5億3,700万人の成人(20~79歳)が糖尿病を患っているといいます。また、糖尿病患者の総数は2030年には6億4,300万人、2045年には7億8,300万人に増加すると予想されています。このように、これらの疾患は一般的に、タンパク質治療薬のような的を絞った個別化治療アプローチを必要とし、その結果、市場の成長はかなりの割合で増大します。さらに、バイオテクノロジーやタンパク質工学の進歩の高まりや、プロテオミクス研究の成長は、予測される数年間に様々な有利な機会をもたらします。しかし、高い生産コストと複雑な製造工程が、2023~2030年の予測期間を通じて市場成長の課題となっています。

世界のタンパク質治療薬市場の調査で考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、バイオテクノロジーの新興国市場の発展、研究開発活動のための資金調達の増加、主要企業の存在により、2022年の市場を独占しました。一方、アジア太平洋は予測期間中に最も高いCAGRで成長すると予想されます。急速に増加する高齢者人口、タンパク質治療薬に対する患者の意識の高まり、慢性疾患の有病率の上昇が、この地域の市場需要を大きく促進しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のタンパク質治療薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界のタンパク質治療薬市場力学

  • タンパク質治療薬市場の影響分析(2020年~2030年)
    • 市場促進要因
      • 生物製剤分野の発展
      • 慢性疾患の増加
    • 市場の課題
      • 高い製造コストが必要
      • 複雑な製造工程
    • 市場機会
      • バイオテクノロジーとタンパク質工学の進歩の高まり
      • プロテオミクス研究の成長

第4章 世界のタンパク質治療薬市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 タンパク質治療薬の世界市場:製品別

  • 市場スナップショット
  • タンパク質治療薬の世界市場:製品別、実績・ポテンシャル分析
  • タンパク質治療薬の世界市場、製品別、推定・予測、2020年~2030年
  • タンパク質治療薬市場、サブセグメント分析
    • モノクローナル抗体
    • インスリン
    • 融合タンパク質
    • エリスロポエチン
    • インターフェロン
    • ヒト成長ホルモン
    • 卵胞刺激ホルモン

第6章 タンパク質治療薬の世界市場:用途別

  • 市場スナップショット
  • タンパク質治療薬の世界市場:用途別、実績・ポテンシャル分析
  • タンパク質治療薬の世界市場、用途別、推定・予測、2020~2030年
  • タンパク質治療薬市場、サブセグメント分析
    • 代謝疾患
    • 免疫疾患
    • がん
    • ホルモン疾患
    • 遺伝子疾患
    • その他

第7章 タンパク質治療薬の世界市場、地域分析

  • 主要国
  • 主な新興国
  • タンパク質治療薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品、推定・予測、2020~2030年
      • 用途別、推定・予測、2020~2030年
    • カナダ
  • 欧州のタンパク質治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋のタンパク質治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカのタンパク質治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東およびアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Novo Nordisk AS
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
    • Baxter International Inc.
    • Amgen Inc.
    • Merck and Co., Inc.
    • Sanofi S.A.
    • Eli Lilly And Company
    • Abbott Laboratories
    • Pfizer Inc.
    • Johnson and Johnson(Janssen Pharmaceuticals)
    • F. Hoffmann La Roche Ltd

第9章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Protein Therapeutics Market, report scope
  • TABLE 2. Global Protein Therapeutics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Protein Therapeutics Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Protein Therapeutics Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Protein Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Protein Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Protein Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Protein Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Protein Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Protein Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Protein Therapeutics Market, research methodology
  • FIG 2. Global Protein Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Protein Therapeutics Market, key trends 2022
  • FIG 5. Global Protein Therapeutics Market, growth prospects 2023-2030
  • FIG 6. Global Protein Therapeutics Market, porters 5 force model
  • FIG 7. Global Protein Therapeutics Market, pest analysis
  • FIG 8. Global Protein Therapeutics Market, value chain analysis
  • FIG 9. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Protein Therapeutics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Protein Therapeutics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Protein Therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Protein Therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Protein Therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Protein Therapeutics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Protein Therapeutics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Protein Therapeutics Market is valued at approximately USD 325.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2023-2030. Protein therapeutics refers to a class of therapeutic agents that are based on proteins or peptides. Proteins are substantial molecules that are crucial for a variety of biological functions, such as immune function, metabolism, and cell signaling. These therapeutic compounds are intended to treat illnesses, disorders, or medical conditions by interacting with certain bodily targets, such as receptors, enzymes, or signaling molecules. The favorable regulatory environment, increase in the geriatric population, and development of the biologics sector, coupled with the rise in healthcare expenditure are the key factors that are spurring the market demand across the globe.

Additionally, the rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases is propelling the demand for protein therapeutics during the estimated period. According to National Cancer Institute, in 2018, the number of cancer patients is estimated to account for 18.1 million, which is projected to reach 29.5 million patients by the year 2040. Moreover, the International Diabetic Federation (IDF) reported that in 2021 approximately 537 million adults (20-79 years) are living with diabetes. Also, the total number of people living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Thus, these conditions generally require targeted and personalized treatment approaches like protein therapeutics, which, in turn, augment the market growth at a considerable rate. Furthermore, the rising advancements in biotechnology and protein engineering, as well as the growth in proteomic research present various lucrative opportunities over the forecasting years. However, the high production costs required and the complex manufacturing processes are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing advancements in biotechnology, growing funding for research and development activities, along with the presence of key players in the region. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rapidly growing geriatric population, increasing patient awareness toward protein therapeutics, as well as rising prevalence of chronic diseases are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Novo Nordisk AS
  • Baxter International Inc.
  • Amgen Inc.
  • Merck and Co., Inc.
  • Sanofi S.A.
  • Eli Lilly And Company
  • Abbott Laboratories
  • Pfizer Inc.
  • Johnson and Johnson (Janssen Pharmaceuticals)
  • F. Hoffmann La Roche Ltd

Recent Developments in the Market:

  • In December 2022, Enlaza Therapeutics announced the introduction with USD 61 million in financing with the objective of advancing the company's first covalent biologic therapeutic platform. The company integrated novel innovations that allow the introduction of proprietary unnatural amino acids to protein drugs, which allows specific covalent binding to their target proteins.

Global Protein Therapeutics Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Monoclonal Antibodies
  • Insulin
  • Fusion Protein
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Follicle Stimulating Hormone

By Application:

  • Metabolic Disorders
  • Immunologic Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Protein Therapeutics Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Protein Therapeutics Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Protein Therapeutics Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Protein Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Protein Therapeutics Market Dynamics

  • 3.1. Protein Therapeutics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Development of the biologics sector
      • 3.1.1.2. Rising prevalence of chronic diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High production costs required
      • 3.1.2.2. Complex manufacturing processes
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising advancements in biotechnology and protein engineering
      • 3.1.3.2. Growth in proteomic research

Chapter 4. Global Protein Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Protein Therapeutics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Protein Therapeutics Market by Product, Performance - Potential Analysis
  • 5.3. Global Protein Therapeutics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Protein Therapeutics Market, Sub Segment Analysis
    • 5.4.1. Monoclonal Antibodies
    • 5.4.2. Insulin
    • 5.4.3. Fusion Protein
    • 5.4.4. Erythropoietin
    • 5.4.5. Interferon
    • 5.4.6. Human Growth Hormone
    • 5.4.7. Follicle Stimulating Hormone

Chapter 6. Global Protein Therapeutics Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Protein Therapeutics Market by Application, Performance - Potential Analysis
  • 6.3. Global Protein Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Protein Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Metabolic Disorders
    • 6.4.2. Immunologic Disorders
    • 6.4.3. Cancer
    • 6.4.4. Hormonal Disorders
    • 6.4.5. Genetic Disorders
    • 6.4.6. Others

Chapter 7. Global Protein Therapeutics Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Protein Therapeutics Market, Regional Market Snapshot
  • 7.4. North America Protein Therapeutics Market
    • 7.4.1. U.S. Protein Therapeutics Market
      • 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Protein Therapeutics Market
  • 7.5. Europe Protein Therapeutics Market Snapshot
    • 7.5.1. U.K. Protein Therapeutics Market
    • 7.5.2. Germany Protein Therapeutics Market
    • 7.5.3. France Protein Therapeutics Market
    • 7.5.4. Spain Protein Therapeutics Market
    • 7.5.5. Italy Protein Therapeutics Market
    • 7.5.6. Rest of Europe Protein Therapeutics Market
  • 7.6. Asia-Pacific Protein Therapeutics Market Snapshot
    • 7.6.1. China Protein Therapeutics Market
    • 7.6.2. India Protein Therapeutics Market
    • 7.6.3. Japan Protein Therapeutics Market
    • 7.6.4. Australia Protein Therapeutics Market
    • 7.6.5. South Korea Protein Therapeutics Market
    • 7.6.6. Rest of Asia Pacific Protein Therapeutics Market
  • 7.7. Latin America Protein Therapeutics Market Snapshot
    • 7.7.1. Brazil Protein Therapeutics Market
    • 7.7.2. Mexico Protein Therapeutics Market
  • 7.8. Middle East & Africa Protein Therapeutics Market
    • 7.8.1. Saudi Arabia Protein Therapeutics Market
    • 7.8.2. South Africa Protein Therapeutics Market
    • 7.8.3. Rest of Middle East & Africa Protein Therapeutics Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Novo Nordisk AS
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Baxter International Inc.
    • 8.3.3. Amgen Inc.
    • 8.3.4. Merck and Co., Inc.
    • 8.3.5. Sanofi S.A.
    • 8.3.6. Eli Lilly And Company
    • 8.3.7. Abbott Laboratories
    • 8.3.8. Pfizer Inc.
    • 8.3.9. Johnson and Johnson (Janssen Pharmaceuticals)
    • 8.3.10. F. Hoffmann La Roche Ltd

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption